← Back to patent-cliff list
CAS 1878192-73-4
2-ethyl-6-(trifluoromethyl)-1,2,3,4-tetrahydroquinolin-4-amine
Codes: OBIC-008
Application context (from source-drug indications)
Myocardial infarctionObicetrapibAtherosclerosisObicetrapibHypercholesterolaemiaObicetrapibHyperlipoproteinaemia type IIObicetrapib代谢病Obicetrapib高脂蛋白血症Obicetrapib
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Obicetrapib | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4-(trifluoromethyl)aniline→N-(2-ethyl-6-(trifluoromethyl)-1,2,3,4-tetrahydroquinolin-4-yl)formamide→2-ethyl-6-(trifluoromethyl)-1,2,3,4-tetrahydroquinolin-4-amine→(2R,3R)-2,3-bis((4-methylbenzoyl)oxy)succinic acid hydrate→(2R,4S)-2-ethyl-6-(trifluoromethyl)-1,2,3,4-tetrahydroquinolin-4-amine (2R,3R)-2,3-bis((4-methylbenzoyl)oxy)succinate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.